Literature DB >> 25336410

Effects of cigarette smoking history on neurocognitive recovery over 8 months of abstinence in alcohol-dependent individuals.

Timothy C Durazzo1, David L Pennington, Thomas P Schmidt, Dieter J Meyerhoff.   

Abstract

BACKGROUND: This study compared the rate and extent of recovery on measures of learning and memory, processing speed, and working memory in treatment-seeking alcohol-dependent individuals (ALC) who were never smokers (nvsALC), former smokers (fsALC), and active smokers (asALC) over the first 8 months of sustained abstinence from alcohol. Assessments after 1 week, 1 month, and 8 months of abstinence in ALC enabled a comparison of the rates of neurocognitive changes from 1 week to 1 month versus 1 to 8 months of abstinence.
METHODS: ALC and never-smoking controls were administered standardized measures of auditory-verbal and visuospatial learning and memory, processing speed, and working memory. Controls completed a baseline assessment and a follow-up approximately 9 months later.
RESULTS: Over 8 months of abstinence, asALC showed poorer recovery than nvsALC on visuospatial learning, and both fsALC and asALC recovered less than nvsALC on processing speed measures. The corresponding recovery rates for the ALC group, as a whole, were greater from 1 week to 1 month than from 1 to 8 months of abstinence; these findings were largely driven by improvements in nvsALC. The recovery levels for fsALC on most measures were similar to those in asALC. Additionally, over 8 months, asALC showed significantly less improvement with increasing age than nvsALC on measures of processing speed and learning and memory. At 8 months of abstinence, asALC were inferior to controls and nvsALC on multiple measures, fsALC performed worse than nvsALC on several tests, but nvsALC were not different from controls on any measure.
CONCLUSIONS: Overall, ALC showed rapid improvement on measures of visuospatial learning and processing speed during the first month of abstinence from alcohol. Results also provide robust evidence that smoking status influenced the rate and level of neurocognitive recovery over 8 months of abstinence in this ALC cohort.
Copyright © 2014 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol Dependence; Cigarette Smoking; Cognition; Longitudinal; Recovery

Mesh:

Year:  2014        PMID: 25336410      PMCID: PMC4245379          DOI: 10.1111/acer.12552

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  21 in total

1.  Chronic smoking is associated with differential neurocognitive recovery in abstinent alcoholic patients: a preliminary investigation.

Authors:  Timothy C Durazzo; Johannes C Rothlind; Stefan Gazdzinski; Peter Banys; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2007-04-19       Impact factor: 3.455

Review 2.  Neurobiological and neurocognitive effects of chronic cigarette smoking and alcoholism.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff
Journal:  Front Biosci       Date:  2007-05-01

3.  Widespread and sustained cognitive deficits in alcoholism: a meta-analysis.

Authors:  Katherine Stavro; Julie Pelletier; Stéphane Potvin
Journal:  Addict Biol       Date:  2012-01-20       Impact factor: 4.280

4.  Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs.

Authors:  Jennifer R Mertens; Constance Weisner; G Thomas Ray; Bruce Fireman; Kevin Walsh
Journal:  Alcohol Clin Exp Res       Date:  2005-06       Impact factor: 3.455

5.  Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study.

Authors:  Timothy C Durazzo; Stefan Gazdzinski; Peter Banys; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2004-12       Impact factor: 3.455

Review 6.  Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.

Authors:  Kristi A Sacco; Katie L Bannon; Tony P George
Journal:  J Psychopharmacol       Date:  2004-12       Impact factor: 4.153

Review 7.  Alcohol: effects on neurobehavioral functions and the brain.

Authors:  Marlene Oscar-Berman; Ksenija Marinković
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

8.  Combined neuroimaging, neurocognitive and psychiatric factors to predict alcohol consumption following treatment for alcohol dependence.

Authors:  Timothy C Durazzo; Stefan Gazdzinski; Ping-Hong Yeh; Dieter J Meyerhoff
Journal:  Alcohol Alcohol       Date:  2008-09-24       Impact factor: 2.826

9.  The relationships of sociodemographic factors, medical, psychiatric, and substance-misuse co-morbidities to neurocognition in short-term abstinent alcohol-dependent individuals.

Authors:  Timothy C Durazzo; Johannes C Rothlind; Stefan Gazdzinski; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2008-09       Impact factor: 2.405

10.  Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.

Authors:  Jennifer R Mertens; Yun W Lu; Sujaya Parthasarathy; Charles Moore; Constance M Weisner
Journal:  Arch Intern Med       Date:  2003-11-10
View more
  11 in total

1.  Cigarette Use Among Individuals with Alcohol Use Disorders in the United States, 2002 to 2016: Trends Overall and by Race/Ethnicity.

Authors:  Andrea H Weinberger; Lauren R Pacek; Daniel Giovenco; Sandro Galea; Michael J Zvolensky; Misato Gbedemah; Renee D Goodwin
Journal:  Alcohol Clin Exp Res       Date:  2018-12-10       Impact factor: 3.455

2.  Chronic Cigarette Smoking in Healthy Middle-Aged Individuals Is Associated With Decreased Regional Brain N-acetylaspartate and Glutamate Levels.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff; Anderson Mon; Christoph Abé; Stefan Gazdzinski; Donna E Murray
Journal:  Biol Psychiatry       Date:  2015-04-09       Impact factor: 13.382

3.  Regional Brain Volume Changes in Alcohol-Dependent Individuals During Short-Term and Long-Term Abstinence.

Authors:  Xiaowei Zou; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2018-05-22       Impact factor: 3.455

4.  Psychiatric, Demographic, and Brain Morphological Predictors of Relapse After Treatment for an Alcohol Use Disorder.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2016-11-24       Impact factor: 3.455

5.  Cerebellar Morphometry and Cognition in the Context of Chronic Alcohol Consumption and Cigarette Smoking.

Authors:  Valerie A Cardenas; Christina M Hough; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2019-11-15       Impact factor: 3.455

6.  White matter microstructural correlates of relapse in alcohol dependence.

Authors:  Yukai Zou; Donna E Murray; Timothy C Durazzo; Thomas P Schmidt; Troy A Murray; Dieter J Meyerhoff
Journal:  Psychiatry Res Neuroimaging       Date:  2018-09-18       Impact factor: 2.376

7.  Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Authors:  Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  J Clin Exp Neuropsychol       Date:  2016-10-03       Impact factor: 2.475

8.  Cigarette smoking history is associated with poorer recovery in multiple neurocognitive domains following treatment for an alcohol use disorder.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2020-01-07       Impact factor: 2.405

9.  Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers.

Authors:  Kyle Bullock; Anita Cservenka; Lara A Ray
Journal:  Am J Drug Alcohol Abuse       Date:  2016-12-20       Impact factor: 3.912

10.  Alcohol use disorder with and without stimulant use: brain morphometry and its associations with cigarette smoking, cognition, and inhibitory control.

Authors:  David L Pennington; Timothy C Durazzo; Thomas P Schmidt; Christoph Abé; Anderson Mon; Dieter J Meyerhoff
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.